CD8A and neoplasm: This combination elicited synergistic antitumor efficacy associated with increased immune infiltration and expansion of Th1 cytokines, tumor-specific immune memory, CD8+ T and NK cell proliferation, and enhancement of tumor antigen-specific CD8+ T cells (43, 44).